List of works by John Wilding

1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes.

scientific article

1α,25(OH)D attenuates IL-6 and IL-1β-mediated inflammatory responses in macrophage conditioned medium-stimulated human white preadipocytes by modulating p44/42 MAPK and NF-κB signaling pathways

article

A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus

scientific article published on 01 October 2012

A parametric analysis of olanzapine-induced weight gain in female rats

scientific article

A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus

scientific article published on 01 November 2018

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

scientific article published on 01 November 2004

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure

scientific article published on 6 April 2007

A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors

scientific article published on 01 April 2019

A role for glucagon-like peptide-1 in the central regulation of feeding

scientific article

A safety evaluation of canagliflozin : a first-in-class treatment for type 2 diabetes

scientific article

A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment

scientific article published on 15 June 2009

A weighty problem

scientific article published in Nature

Abnormal heart rate variability in adults with growth hormone deficiency

scientific article published on 01 February 2000

Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus

scientific article published on 29 December 2012

Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for GLP-1 in modulation of the diabetic pro-inflammatory state?

scientific article published on 13 March 2013

Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats.

scientific article

Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C

article

Altered Left Ventricular Ion Channel Transcriptome in a High-Fat-Fed Rat Model of Obesity: Insight into Obesity-Induced Arrhythmogenesis

scientific article published on 25 September 2016

Are the causes of obesity primarily environmental? Yes

scientific article published on 11 September 2012

Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction.

scientific article published on 14 August 2017

Assessing the cost-effectiveness of SGLT2i in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real-world evidence

scientific article published on 03 August 2020

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

scientific article published in July 2003

Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK.

scientific article published on 24 April 2018

Body weight and prolactinoma: a retrospective study

scientific article published on 01 January 2004

Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents -Post-hoc Analyses from DECLARE-TIMI 58

scientific article published on 26 August 2020

Cardiovascular and metabolic effects of CPAP in obese males with OSA.

scientific article published on 24 January 2007

Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial

scientific article published on 23 February 2020

Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease.

scientific article published on April 2007

Cardiovascular outcome trials in obesity: A review

scientific article published on 07 September 2020

Cerebral activations during viewing of food stimuli in adult patients with acquired structural hypothalamic damage: a functional neuroimaging study

scientific article published on 14 May 2015

Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.

scientific article published on 16 July 2018

Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.

scientific article

Clinical evaluation of anti-obesity drugs

scientific article published on April 2004

Combination therapy for obesity

scientific article published in November 2017

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

scientific article published on 01 April 2019

Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)-study protocol.

scientific article published on 27 January 2017

Correction to: Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C

scientific article published on 01 April 2019

Correction to: Cardiac Autonomic Neuropathy in Obesity, Metabolic Syndrome and Prediabetes: A Narrative Review

scientific article published on 01 December 2019

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice

scientific article published on 01 October 2019

Correlations between night eating, sleep quality, and excessive daytime sleepiness in a severely obese UK population

scientific article published on 8 August 2013

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction

scientific article published on 18 March 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 10 November 2018

Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time.

scientific article published on 28 November 2014

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.

scientific article published on 29 August 2013

Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes

scientific article published on 18 February 2020

Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up

scientific article published on 02 June 2017

Declare-Timi 58: Participants' Baseline Characteristics

scientific article published on 11 January 2018

Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in rats

scientific article published on May 1, 1992

Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study.

scientific article published on 14 June 2007

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

scientific article published on 15 December 2016

Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin

scientific article published on 24 March 2013

Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone

scientific article published in April 2000

Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle

article

Effect of CPAP on arterial stiffness in severely obese patients with obstructive sleep apnoea

scientific article published on 6 February 2015

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

scientific article published on 18 March 2019

Effect of a cooked meat meal on serum creatinine and estimated glomerular filtration rate in diabetes-related kidney disease.

scientific article published on 23 September 2013

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial

scientific article

Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat.

scientific article published in January 2007

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.

scientific article

Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.

scientific article published in August 2012

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

scientific article published on 11 January 2012

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

scientific article published on 10 June 2019

Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.

scientific article published on 18 October 2006

Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes.

scientific article published on 20 October 2008

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

scientific article published in May 2000

Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus

scientific article published on 31 December 2014

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

scientific article

Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study.

scientific article

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

scientific article published on 16 August 2018

Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes.

scientific article published on September 2013

Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition

scientific article published on 25 September 2015

Evaluation of Aintree LOSS, a community-based, multidisciplinary weight management service: outcomes and predictors of engagement

scientific article published on 4 September 2017

Exposure-response analyses of liraglutide 3.0 mg for weight management.

scientific article published on 02 February 2016

Facing the challenges for Europe--research into action: Liverpool European Congress of Obesity, May 12-15, 2013

scientific article published on 07 September 2012

Fasting plasma peptide-YY concentrations are elevated but do not rise postprandially in type 2 diabetes.

scientific article published on 11 July 2006

Fit for Birth - the effect of weight changes in obese pregnant women on maternal and neonatal outcomes: a pilot prospective cohort study.

scientific article published on 6 January 2016

GLP-1 as a target for therapeutic intervention.

scientific article

Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation.

scientific article published on 9 May 2011

Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects

scientific article published on 3 February 2009

Ghrelin: sweet regulation?

Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus

scientific article published on 01 June 1997

Glucagon-like peptide-1 analogues for type 2 diabetes

scientific article published on 16 February 2011

Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response

scientific article published on 10 January 2017

Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus

scientific article published on 17 July 2019

Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study

scientific article published on September 2016

Growth hormone and changes in energy balance in growth hormone deficient adults.

scientific article published in September 2008

Gut peptides and the regulation of appetite.

scientific article

How to approach endocrine assessment in severe obesity?

scientific article published in August 2013

Human RBP4 adipose tissue expression is gender specific and influenced by leptin.

scientific article

Hypothalamic obesity in humans: what do we know and what can be done?

scientific article

Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic

scientific article published on 15 March 2013

Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes

scientific article published on 12 December 2008

Impact of bariatric surgery on physical functioning in obese adults

scientific article published on 12 January 2015

Improved glycaemic control--an unintended benefit of a nurse-led cardiovascular risk reduction clinic

scientific article published in September 2005

In humans the adiponectin receptor R2 is expressed predominantly in adipose tissue and linked to the adipose tissue expression of MMIF-1

scientific article published on 01 April 2010

Incorporating patients' perspectives into the initial stages of core outcome set development: a rapid review of qualitative studies of type 2 diabetes

scientific article published on 28 February 2019

Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats.

scientific article published in February 1992

Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.

scientific article published on June 2001

Intensified treatment of type 2 diabetes--positive effects on blood pressure, but not glycaemic control

scientific article published in November 2003

Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?

scientific article published on 21 June 2005

Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects

scientific article

Leptin and the control of obesity.

scientific article

Liraglutide in the treatment of obesity.

scientific article

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin

scientific article

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot

scientific article published on 18 May 2017

Medication use for the treatment of diabetes in obese individuals.

scientific article

Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes

scientific article published on 01 May 2007

Modern management of obesity.

scientific article published on December 2009

Naloxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: evidence for neuropeptide Y-opioid interactions in the control of food intake

scientific article

Neuropeptides and appetite control.

scientific article

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.

scientific article published on 6 April 2017

Newer GLP-1 receptor agonists and obesity-diabetes.

scientific article published in February 2018

Night eating syndrome: implications for severe obesity

scientific article

Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up study

scientific article published on 01 August 2010

Obesity and Type 2 diabetes mellitus

scientific article published on 01 May 2000

Obesity and diabetes.

scientific article

Obesity and risk of myocardial infarction: the INTERHEART study

scientific article published in The Lancet

Obesity and type-2 diabetes in the elderly.

scientific article

Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management

scientific article published on 06 September 2018

Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.

scientific article published on 10 May 2017

Obesity: under-diagnosed and under-treated in hospital outpatient departments

scientific article published on 01 April 2002

Obstructive sleep apnea is associated with increased arterial stiffness in severe obesity.

scientific article

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

scientific article published in May 2004

Orlistat: should we worry about liver inflammation?

scientific article published on 30 April 2013

Patients' Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography

scientific article published on 17 August 2018

Peripheral injection of risperidone, an atypical antipsychotic, alters the body weight gains of rats

scientific article

Physical Activity and Sedentary Time: Association with Metabolic Health and Liver Fat

scientific article published on 01 June 2019

Plasma adiponectin increases postprandially in obese, but not in lean, subjects.

scientific article

Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged

scientific article

Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal.

scientific article published on 31 July 2007

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.

scientific article published on April 2006

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

scientific article published on 17 April 2018

Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity

scientific article published on 01 April 1996

Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance

scientific article published in August 2004

Reply to Camargo et al

scientific article published on 01 August 2012

Research update for articles published in EJCI in 2014

scientific article published on 01 October 2016

Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of

scientific article published in February 2018

Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma.

scientific article published on 25 August 2011

Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira

scientific article

SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials

scientific article published on 15 December 2017

SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

scientific article published on 23 July 2018

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice

scientific article published on 09 July 2019

SGLT2 inhibitors and urinary tract infections

scientific article published on 01 December 2019

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

scientific article published in The Lancet

SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?

scientific article published on 18 March 2016

SPARC: a key player in the pathologies associated with obesity and diabetes.

scientific article published on 02 March 2010

Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

scientific article published on 12 October 2019

Safety of dapagliflozin in a broad population of patients with type 2 diabetes - analyses from the DECLARE - TIMI 58 study

scientific article published on 02 April 2020

Screening methods for obstructive sleep apnoea in severely obese pregnant women.

scientific article published on 29 May 2017

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

scientific article published on 07 August 2018

Semaglutide in weight management - Author's reply

scientific article published on 01 October 2019

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

scientific article published on 12 June 2018

Serum urate and obstructive sleep apnoea in severe obesity

scientific article published on 19 May 2015

Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes.

scientific article published on 18 April 2018

Should obesity be recognised as a disease?

scientific article published on 17 July 2019

Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y

scientific article

Sleep disordered breathing--a new component of syndrome x?

scientific article

Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome

scientific article published on 03 October 2014

Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus.

scientific article

Strengthening resistance to the COVID-19 pandemic and fostering future resilience requires concerted action on obesity

scientific article published on 01 December 2020

Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

scientific article published on 01 October 2020

Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes.

scientific article

The 1α,25(OH)2D3 Analogs ZK159222 and ZK191784 Show Anti-Inflammatory Properties in Macrophage-Induced Preadipocytes via Modulating the NF-κB and MAPK Signaling

scientific article published on 19 May 2020

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula performs worse than the Modification of Diet in Renal Disease (MDRD) equation in estimating glomerular filtration rate in Type 2 diabetic chronic kidney disease.

scientific article published in October 2011

The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity

scientific article published on 22 June 2009

The cost-effectiveness of dapagliflozin in treating high risk patients with type 2 diabetes mellitus: an economic evaluation using data from the DECLARE-TIMI 58 trial

scientific article published on 28 December 2020

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

scientific article published on 07 February 2018

The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.

scientific article published on February 2005

The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat.

scientific article

The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: real effects or expectation of benefit?

scientific article

The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women

scientific article published on 28 August 2008

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection

scientific article published on 27 October 2020

The four-variable modification of diet in renal disease formula underestimates glomerular filtration rate in obese type 2 diabetic individuals with chronic kidney disease

scientific article published on 26 February 2011

The importance of free fatty acids in the development of Type 2 diabetes.

scientific article published on September 2007

The importance of weight management in type 2 diabetes mellitus.

scientific article

The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)

scientific article published on 20 November 2019

The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency

scientific article published on 01 June 2001

The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency.

scientific article published in January 2004

The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.

scientific article published on 02 July 2014

Thiazolidinediones, insulin resistance and obesity: Finding a balance.

scientific article published on October 2006

Time for a new obesity narrative

scientific article published in The Lancet

Treatment strategies for obesity.

scientific article published on March 2007

Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats

scientific article

Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment

scientific article

Urinary proteomics in obstructive sleep apnoea and obesity.

scientific article published in November 2014

Vitamin D receptor ligands attenuate the inflammatory profile of IL-1β-stimulated human white preadipocytes via modulating the NF-κB and unfolded protein response pathways

scientific article published on 23 June 2018

Vitamin D signalling in adipose tissue.

scientific article published on 09 October 2012

Weighing up dietary patterns – Authors' reply

scientific article published in August 2016

Weight loss is the major player in bariatric surgery benefits

scientific article published on 15 October 2020

Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities

scientific article published on 10 April 2019

Weight management and cardiovascular disease: implications of recent and ongoing clinical trials

What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?

scientific article published on 12 January 2017

Why i eat at night: A qualitative exploration of the development, maintenance and consequences of Night Eating Syndrome.

scientific article published on 14 February 2018

c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y

scientific article published on 01 January 1995

Paulina is supported by:

About Paulina

Help